Analytical Considerations for the Biochemical Assessment of Vitamin D Status

Overview

Journal Ther Adv Musculoskelet Dis

Date 2017 Apr 7

PMID 28382113

Citations 11

Authors

Lewis Couchman

Cajetan F Moniz

Affiliations

Soon will be listed here.

Abstract

The most widely used and clinically accepted biochemical marker for assessing vitamin D status is the total serum 25-hydroxyvitamin D [25(OH)D] concentration. Despite the analysis of 25(OH)D dating back to the early 1970s, modern analytical techniques still exhibit significant interassay variability due to varying concentrations of other related vitamin D metabolites and sample-to-sample matrix differences. It is important for clinicians requesting 25(OH)D analyses to understand these issues and limitations, and where necessary to confront laboratories for details of analytical methods used. The availability of reference measurement procedures for 25(OH)D based on liquid chromatography and tandem mass spectrometry, whilst not intended for routine clinical sample analysis, should be utilized to improve assay harmonization and reduce interlaboratory variability. Laboratories should also be forthcoming with details of subscriptions to external quality assessment schemes and assay traceability. As well as discussing the reasons for ongoing assay variability for 25(OH)D, this short review will also briefly discuss other assays related to the assessment of vitamin D status, including parathyroid hormone, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D and vitamin D binding proteins.

Citing Articles

Laboratory considerations in the assessment of 25-hydroxyvitamin D in pregnant women by automated immunoassays.

Khalid D, Nouri B, Mustafa S, Abdi M Pract Lab Med. 2024; 42:e00430.

PMID: 39399546 PMC: 11470585. DOI: 10.1016/j.plabm.2024.e00430.

Effect of 12-Week BMI-Based Vitamin D Supplementation in Parkinson's Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites.

Bytowska Z, Korewo-Labelle D, Berezka P, Kowalski K, Przewlocka K, Libionka W Int J Mol Sci. 2023; 24(12).

PMID: 37373347 PMC: 10299437. DOI: 10.3390/ijms241210200.

The Edge Effect in High-Throughput Proteomics: A Cautionary Tale.

Maxwell C, Sandhu J, Cao T, McCann G, Ng L, Jones D J Am Soc Mass Spectrom. 2023; 34(6):1065-1072.

PMID: 37155737 PMC: 10251511. DOI: 10.1021/jasms.3c00035.

Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine.

Hu Y, Wang Z, Liu L, Zhu J, Zhang D, Xu M Chem Sci. 2021; 12(23):7993-8009.

PMID: 34257858 PMC: 8230026. DOI: 10.1039/d1sc00271f.

A LC-MS method for 25-hydroxy-vitamin D3 measurements from dried blood spots for an epidemiological survey in India.

Lote-Oke R, Pawar J, Kulkarni S, Sanas P, Kajale N, Gondhalekar K Sci Rep. 2020; 10(1):19873.

PMID: 33199793 PMC: 7670412. DOI: 10.1038/s41598-020-76955-w.

References

Pludowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokol D, Czech-Kowalska J . Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64(4):319-27. DOI: 10.5603/ep.2013.0012. View

Mineva E, Schleicher R, Chaudhary-Webb M, Maw K, Botelho J, Vesper H . A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D₃ and 25-hydroxyvitamin D₂ using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2015; 407(19):5615-24. PMC: 4823009. DOI: 10.1007/s00216-015-8733-z. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Singh R, Taylor R, Reddy G, Grebe S . C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006; 91(8):3055-61. DOI: 10.1210/jc.2006-0710. View

Speeckaert M, Huang G, Delanghe J, Taes Y . Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006; 372(1-2):33-42. DOI: 10.1016/j.cca.2006.03.011. View

Kaufmann M, Gallagher J, Peacock M, Schlingmann K, Konrad M, Deluca H . Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 2014; 99(7):2567-74. PMC: 4079315. DOI: 10.1210/jc.2013-4388. View

Keevil B . Does the presence of 3-epi-25OHD3 affect the routine measurement of vitamin D using liquid chromatography tandem mass spectrometry?. Clin Chem Lab Med. 2011; 50(1):181-3. DOI: 10.1515/CCLM.2011.755. View

Deluca H, Prahl J, Plum L . 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch Biochem Biophys. 2010; 505(2):226-30. DOI: 10.1016/j.abb.2010.10.012. View

Lips P . Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res. 2007; 22(11):1668-71. DOI: 10.1359/jbmr.070716. View

10.

Carter G, Phinney K . Assessing vitamin D status: time for a rethink?. Clin Chem. 2014; 60(6):809-11. DOI: 10.1373/clinchem.2013.219386. View

11.

Stockl D, Sluss P, Thienpont L . Specifications for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D analysis. Clin Chim Acta. 2009; 408(1-2):8-13. DOI: 10.1016/j.cca.2009.06.027. View

12.

Need A, Horowitz M, Morris H, Nordin B . Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women. Am J Clin Nutr. 2000; 71(6):1577-81. DOI: 10.1093/ajcn/71.6.1577. View

13.

Svasti J, Kurosky A, Bennett A, BOWMAN B . Molecular basis for the three major forms of human serum vitamin D binding protein (group-specific component). Biochemistry. 1979; 18(8):1611-7. DOI: 10.1021/bi00575a036. View

14.

Stepman H, Vanderroost A, Van Uytfanghe K, Thienpont L . Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011; 57(3):441-8. DOI: 10.1373/clinchem.2010.152553. View

15.

Cooke N, David E . Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest. 1985; 76(6):2420-4. PMC: 424397. DOI: 10.1172/JCI112256. View

16.

Couchman L, Taylor D, Krastins B, Lopez M, Moniz C . LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations. Clin Chem Lab Med. 2014; 52(9):1251-63. DOI: 10.1515/cclm-2014-0150. View

17.

Garrett G, Sardiwal S, Lamb E, Goldsmith D . PTH--a particularly tricky hormone: why measure it at all in kidney patients?. Clin J Am Soc Nephrol. 2012; 8(2):299-312. DOI: 10.2215/CJN.09580911. View

18.

Bischoff-Ferrari H, Dawson-Hughes B, Orav E, Staehelin H, Meyer O, Theiler R . Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med. 2016; 176(2):175-83. DOI: 10.1001/jamainternmed.2015.7148. View

19.

Sahota O, Mundey M, San P, Godber I, Lawson N, Hosking D . The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004; 35(1):312-9. DOI: 10.1016/j.bone.2004.02.003. View

20.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View